Back to Search Start Over

Thyroid Cancer and COVID-19: Prospects for Therapeutic Approaches and Drug Development

Authors :
Na Qu
Zongguang Hui
Zhixin Shen
Chengxia Kan
Ningning Hou
Xiaodong Sun
Fang Han
Source :
Frontiers in endocrinology. 13
Publication Year :
2022

Abstract

Thyroid cancer is the most prevalent endocrine malignancy and the reported incidence of thyroid cancer has continued to increase in recent years. Since 2019, coronavirus disease 2019 (COVID-19) has been spreading worldwide in a global pandemic. COVID-19 aggravates primary illnesses and affects disease management; relevant changes include delayed diagnosis and treatment. The thyroid is an endocrine organ that is susceptible to autoimmune attack; thus, thyroid cancer after COVID-19 has gradually attracted attention. Whether COVID-19 affects the diagnosis and treatment of thyroid cancer has also attracted the attention of many researchers. This review examines the literature regarding the influence of COVID-19 on the pathogenesis, diagnosis, and treatment of thyroid cancer; it also focuses on drug therapies to promote research into strategies for improving therapy and management in thyroid cancer patients with COVID-19.

Details

ISSN :
16642392
Volume :
13
Database :
OpenAIRE
Journal :
Frontiers in endocrinology
Accession number :
edsair.doi.dedup.....d939d74b95c7029a53c6610e9570edfa